Shaun Wood is a Psychiatry physician. OpenAlex indexes 26 publications with 288 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8401 Harcourt Rd
Indianapolis, IN 462602036
Telephone
317-338-4600Registry record last updated 11 Jan 2017.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teva Pharmaceuticals USA, Inc.Program year20251 payment
- Janssen Pharmaceuticals, IncProgram year20242 payments
- Otsuka America Pharmaceutical, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI41%Sertraline Hcl51%Trazodone Hcl27%Escitalopram Oxalate13%Fluoxetine Hcl9%Part D<11 patientsAtypical Antipsychotic28%Quetiapine Fumarate41%Risperidone39%Olanzapine21%Part D≥24 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- BPS2026 - Development of selective claudin channel blockers for claudin-15 and claudin-2
Biophysical Journal
2026 - Cryo-electron tomography reveals paracellular claudin-15 pores at the tight junction
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease
EMBO Molecular Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”